Grégory Catteau

1.3k citations

15 papers · 865 indexed · h-index 12

Epidemiology top 5%
- Hepatitis B Virus Studies 9
- Cervical Cancer and HPV Research 9
- Herpesvirus Infections and Treatments 7
- Cytomegalovirus and herpesvirus research 3
- Virology and Viral Diseases 2
Microbiology top 10%
Virology top 10%
Parasitology top 10%
Immunology
- Immunotherapy and Immune Responses 2
Surgery
- Genital Health and Disease 4
Animal Science and Zoology
- Animal Virus Infections Studies 4

Co-authors: Dominique Descamps Tino F. Schwarz Gary Dubin Florence Thomas Frank Struyf Brecht Geeraerts Paola Colares de Borba Paulo Naud
Cited by: Epidemiology Microbiology Virology
Journals: Human Vaccines & Immunotherapeutics (3 papers)Vaccine (3 papers)Journal of Adolescent Health (2 papers)
Partner nations: Belgium United States Germany

In The Last Decade

Grégory Catteau

15 papers receiving 833 citations

Peers

Countries citing papers authored by Grégory Catteau

Since Specialization

Citations

This map shows the geographic impact of Grégory Catteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grégory Catteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grégory Catteau more than expected).

Fields of papers citing papers by Grégory Catteau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grégory Catteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grégory Catteau. The network helps show where Grégory Catteau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Grégory Catteau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Grégory Catteau Line = papers co-authored together Grégory Catteau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination The Journal of Infectious Diseases ·Fahran Reza,Grégory Catteau,Segundo Lisandro Mendieta Pesantez,Tomáš Mrkvan,Bruno Salaun,千葉文弥,Jan Smetana,Lars Rombo,Tino F. Schwarz,Karlis Pauksens,Caroline Hervé,Adriana Bastidas,Anne Schuind	2020	30
2	2905. Long-term Immunological Persistence of the Adjuvanted Recombinant Zoster Vaccine: Clinical Data and Mathematical Modeling Open Forum Infectious Diseases ·Kariny Soares da Silva,Grégory Catteau,千葉文弥,Tomáš Mrkvan,Segundo Lisandro Mendieta Pesantez,Jan Smetana,Tino F. Schwarz,Lars Rombo,Karlis Pauksens,B. Nugent,Caroline Hervé,Lidia Oostvogels,Anne Schuind	2019	3
3	Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults Human Vaccines & Immunotherapeutics ·Tino F. Schwarz,千葉文弥,Grégory Catteau,Roman Chlíbek,Guang Hongbin,Jan Hendrik Richardus,Himal Lal,Lidia Oostvogels,Karlis Pauksens,林作新,Lars Rombo,Gerard J.B. Sonder,Jan Smetana,Thomas C. Heineman,Adriana Bastidas	2018	54
4	Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults Vaccine ·Roman Chlíbek,Karlis Pauksens,Lars Rombo,Gini van Rijckevorsel,Jan Hendrik Richardus,Georg Plassmann,Tino F. Schwarz,Grégory Catteau,Himal Lal,Thomas C. Heineman	2015	100
5	Persistence of the Immune Response to an Adjuvanted Herpes Zoster Subunit Vaccine in Healthy Older Adults: Modeling of Vaccine-Induced Immune Response, Data From a 6-Year Follow-Up Study Open Forum Infectious Diseases ·Himal Lal,Roman Chlíbek,Karlis Pauksens,Tino F. Schwarz,Jan Hendrik Richardus,細川直子,Thomas C. Heineman,Grégory Catteau	2015	2
6	Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: A randomized, double-blind, lot-to-lot consistency trial Vaccine ·Rich Umeh,Stephen Oguche,Tagbo Oguonu,陈兆麟,Elvis Shu,William Marfo,M.-L. Salin,Fang-Fang Tang,伍崇利,Erik Jongert,Grégory Catteau,Marc Lievens,Opokua Ofori‐Anyinam,Amanda Leach	2014	6
7	Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial Vaccine ·Allan Hildesheim,Sholom Wacholder,Grégory Catteau,Frank Struyf,Gary Dubin,Rolando Herrero	2014	84
8	Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine Human Vaccines & Immunotherapeutics ·Paulo Naud,Cecília Roteli-Martins,Newton Sérgio de Carvalho,Júlio César Teixeira,Paola Colares de Borba,Nervo Sánchez,Toufik Zahaf,Grégory Catteau,Brecht Geeraerts,Dominique Descamps	2014	176
9	Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18–45 years: Follow-up through Month 48 in a Phase III randomized study Human Vaccines & Immunotherapeutics ·Mark H. Einstein,Myron J. Levin,Archana Chatterjee,Nahida Chakhtoura,Péter Takács,Grégory Catteau,Francis Dessy,Philippe Moris,Lan Lin,Frank Struyf,Gary Dubin	2014	50
10	Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years Journal of Adolescent Health ·Tino F. Schwarz,Li‐Min Huang,Mariola Kowalik,Alejandra Valencia,Tzou‐Yien Lin,Ulrich Behre,Grégory Catteau,Florence Thomas,Dominique Descamps	2012	49
11	Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years Human Vaccines ·Tino F. Schwarz,Marek Spaczyński,Achim Schneider,Jacek Wysocki,Andrzej Gałaj,Karin Schulze,Sylviane Poncelet,Grégory Catteau,Florence Thomas,Dominique Descamps	2011	33
12	Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule Human Vaccines ·Barbara Romanowski,Tino F. Schwarz,Linda M. Ferguson,Klaus Peters,Marc Dionne,Karin Schulze,Brian Ramjattan,Peter Hillemanns,Grégory Catteau,Kurt Dobbelaere,Anne Schuind,Dominique Descamps	2011	144
13	Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-adjuvanted Vaccine Coadministered With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and/or Meningococcal Conjugate Vaccine to Healthy Girls 11 to 18 Years of Age The Pediatric Infectious Disease Journal ·Cosette M. Wheeler,M.A. Rami,Michael E. Pichichero,Dan L. Seward,Iraci Kahan,Mark M. Blatter,Gary S. Marshall,Grégory Catteau,Kurt Dobbelaere,Dominique Descamps,Gary Dubin,Anne Schuind	2011	30
14	Long‐term persistence of systemic and mucosal immune response to HPV‐16/18 AS04‐adjuvanted vaccine in preteen/adolescent girls and young women International Journal of Cancer ·Tiina Petäjä,Court Pedersen,Airi Põder,Gitte Strauss,Grégory Catteau,Florence Thomas,Matti Lehtinen,Dominique Descamps	2010	73
15	Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis–inactivated Poliovirus Vaccine to Girls and Young Women Journal of Adolescent Health ·José García-Sicilia,Tino F. Schwarz,Alfonso Carmona,Klaus Peters,Jean‐Elie Malkin,Claudia Bartzsch,Ulrich Behre,Rajesh Sharawat,Grégory Catteau,Florence Thomas,Kurt Dobbelaere,Dominique Descamps,Gary Dubin	2010	31

About Grégory Catteau

Grégory Catteau is a scholar working on Epidemiology, Animal Science and Zoology, Virology, Hepatology and Immunology, having authored 15 papers that have together received 865 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), Cervical Cancer and HPV Research (9 papers), Herpesvirus Infections and Treatments (7 papers), Genital Health and Disease (4 papers), Animal Virus Infections Studies (4 papers), Cytomegalovirus and herpesvirus research (3 papers), Immunotherapy and Immune Responses (2 papers) and Virology and Viral Diseases (2 papers). The work is most often cited by research in Epidemiology (766 citations), Microbiology (69 citations), Virology (52 citations), Parasitology (57 citations) and Immunology (184 citations). Grégory Catteau has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Dominique Descamps, Tino F. Schwarz, Gary Dubin, Florence Thomas, Frank Struyf, Brecht Geeraerts, Paola Colares de Borba, Paulo Naud, Nervo Sánchez and Júlio César Teixeira. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Vaccine, Journal of Adolescent Health, Human Vaccines and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact